Get started
Prime Medicine, Inc.Prime Medicine, Inc.Prime Medicine, Inc.

Prime Medicine, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

PRME chart


Full chart

PRME upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪261.01 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.70 USD
Net income (FY)
‪−195.88 M‬ USD
Revenue (FY)
‪2.98 M‬ USD
Shares float
‪51.92 M‬
Beta (1Y)
3.11

Employees


Employees (FY)
214
Change (1Y)
−20 −8.55%
Revenue / Employee (1Y)
‪13.94 K‬ USD
Net income / Employee (1Y)
‪−915.34 K‬ USD

About Prime Medicine, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Keith M. Gottesdiener
Website
primemedicine.com
Headquarters
Cambridge
Founded
2019
FIGI
BBG011RT3R55
Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

PRME news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as PRME.

Frequently Asked Questions


The current price of PRME is 1.99 USD — it has decreased by −0.50% in the past 24 hours. Watch Prime Medicine, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Prime Medicine, Inc. stocks are traded under the ticker PRME.
PRME stock has risen by 2.05% compared to the previous week, the month change is a −26.30% fall, over the last year Prime Medicine, Inc. has showed a −70.86% decrease.
We've gathered analysts' opinions on Prime Medicine, Inc. future price: according to them, PRME price has a max estimate of 19.00 USD and a min estimate of 6.00 USD. Watch PRME chart and read a more detailed Prime Medicine, Inc. stock forecast: see what analysts think of Prime Medicine, Inc. and suggest that you do with its stocks.
PRME reached its all-time high on Nov 14, 2022 with the price of 21.73 USD, and its all-time low was 1.65 USD and was reached on Mar 18, 2025. View more price dynamics on PRME chart.
See other stocks reaching their highest and lowest prices.
PRME stock is 8.40% volatile and has beta coefficient of 3.11. Track Prime Medicine, Inc. stock price on the chart and check out the list of the most volatile stocks — is Prime Medicine, Inc. there?
Today Prime Medicine, Inc. has the market capitalization of ‪261.01 M‬, it has decreased by −7.89% over the last week.
Yes, you can track Prime Medicine, Inc. financials in yearly and quarterly reports right on TradingView.
Prime Medicine, Inc. is going to release the next earnings report on May 9, 2025. Keep track of upcoming events with our Earnings Calendar.
PRME earnings for the last quarter are −0.31 USD per share, whereas the estimation was −0.35 USD resulting in a 11.61% surprise. The estimated earnings for the next quarter are −0.31 USD per share. See more details about Prime Medicine, Inc. earnings.
Prime Medicine, Inc. revenue for the last quarter amounts to ‪2.20 M‬ USD, despite the estimated figure of ‪6.78 M‬ USD. In the next quarter, revenue is expected to reach ‪4.49 M‬ USD.
PRME net income for the last quarter is ‪−42.28 M‬ USD, while the quarter before that showed ‪−52.52 M‬ USD of net income which accounts for 19.50% change. Track more Prime Medicine, Inc. financial stats to get the full picture.
No, PRME doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 31, 2025, the company has 214 employees. See our rating of the largest employees — is Prime Medicine, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Prime Medicine, Inc. EBITDA is ‪−196.34 M‬ USD, and current EBITDA margin is ‪−6.58 K‬%. See more stats in Prime Medicine, Inc. financial statements.
Like other stocks, PRME shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Prime Medicine, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Prime Medicine, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Prime Medicine, Inc. stock shows the sell signal. See more of Prime Medicine, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.